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ABSTRACT SP-A, the major protein component of pulmonary surfactant, is absent in exogenous surfactants currently used in
clinical practice. However, it is thought that therapeutic properties of natural surfactants improve after enrichment with SP-A.
The objective of this study was to determine SP-A effects on physical properties and surface activity of a new synthetic lung
surfactant based on a cationic and hydrophobic 21-residue peptide KLLLLKLLLLKLLLLKLLLLK, KL4. We have analyzed the
interaction of SP-A with liposomes consisting of DPPC/POPG/PA (28:9:5.6, w/w/w) with and without 0.57 mol % KL4 peptide.
We found that SP-A had a concentration-dependent effect on the surface activity of KL4-DPPC/POPG/PA membranes but not
on that of an animal-derived LES. The surface activity of KL4-surfactant signiﬁcantly improved after enrichment with 2.5–5 wt %
SP-A. However, it worsened at SP-A concentrations $10 wt %. This was due to the ﬂuidizing effect of supraphysiological SP-A
concentrations on KL4-DPPC/POPG/PA membranes as determined by ﬂuorescence anisotropy measurements, calorimetric
studies, and confocal ﬂuorescence microscopy of GUVs. High SP-A concentrations caused disappearance of the solid/ﬂuid
phase coexistence of KL4-surfactant, suggesting that phase coexistence might be important for the surface adsorption process.
INTRODUCTION
Pulmonary surfactant is a heterogeneous lipid-protein com-
plex that overlies the alveolar epithelium and stabilizes the
lung by reducing surface tension in the alveolus (1,2). This
makes breathing easier and prevents alveolar edema. Sur-
factant is also involved in lung defense against inhaled
pathogens and toxins and modulates the function of respi-
ratory inﬂammatory cells (3). Lung immaturity and surfac-
tant deﬁciency are the main factors in the pathogenesis of
neonatal RDS. Surfactant dysfunction, caused by inactiva-
tion of surface active material in the airspaces, also con-
tributes to respiratory failure in other forms of neonatal lung
disease, such as meconium aspiration syndrome, and in
ARDS (3–5).
Surfactant is composed of 90 wt % lipids and 10 wt %
proteins. PLs are the major lipid component of surfactant,
especially DPPC (1,2). PG represents a major unsaturated
anionic component (1,2). Four surfactant proteins have been
reported to exist in this material: the hydrophobic proteins
SP-B and SP-C, which are inserted in surfactant membranes,
and the collectins SP-A and SP-D. SP-B is a small hydro-
phobic protein that is essential for lung function and pul-
monary homeostasis after birth. SP-B constitutes 0.7% of the
total mass of isolated surfactant (1). Genetic absence of SP-B
in both human beings and mice results in a lack of alveolar
expansion and a lethal failure of pulmonary function (4). In
contrast, genetic absence of SP-C, another small hydropho-
bic protein that constitutes 0.5 wt %, results in normal
expansion of alveoli and pulmonary function (4). Both hy-
drophobic proteins enhance the spreading, adsorption, and
stability of surfactant lipids required for the reduction of
surface tension in the alveolus (1,2,4). SP-A and SP-D are
large oligomeric proteins that belong to the collectin family
involved in immune innate host defense (3). They are char-
acterized by an N-terminal collagen-like domain and a glob-
ular C-terminal domain that includes a C-type CRD (3,6).
SP-A comprises;3–4% of the total mass of surfactant and is
mainly associated with surfactant lipids (2,7). SP-D, on the
other hand, constitutes;0.5 wt % and is not associated with
lipids (2). SP-A’s ability to bind lipids 1), improves the
adsorption and spreading of surfactant membranes onto an
air-liquid interface (8,9); 2), protects surfactant biophysical
activity from the inhibitory action of serum proteins (9); and
3), allows this protein to position and concentrate along with
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surfactant membranes at the front lines of defense against
inhaled toxins or pathogens (3,6).
Airway instillation of surfactant is in general use for
treatment of RDS in preterm babies (5). Replacement sur-
factants consist of lipid extract preparations obtained from
animal bronchoalveolar ﬂuids. Common components in
these preparations are PLs, mainly DPPC, and the hydro-
phobic proteins SP-B and SP-C (5). Replacement surfactants
do not contain SP-A. Lung function is apparently maintained
with a surfactant devoid of SP-A at sufﬁcient concentrations
(10). However, several authors indicate that surfactant po-
tency is impaired in the absence of SP-A (11,12). Bernhard
and co-workers (12) concluded that the reduced SP-B/C
content found in commercial replacement surfactants, to-
gether with the absence of SP-A, could be the reason for the
diminished surface activity of replacement surfactants com-
pared with native surfactants. This view is reinforced by the
facts that addition of SP-A to a modiﬁed replacement
surfactant (Survanta) enhances the therapeutic effect of this
surfactant on dynamic and static lung compliance in ven-
tilated premature newborn rabbits (13) and that it improves
the physical and therapeutic properties of another animal-
derived surfactant (Curosurf) (14).
Currently, many efforts are being made to develop
synthetic surfactants since natural surfactants from animal
sources involve microbiological, immunological, economic,
and purity concerns. Synthetic surfactants consist of com-
binations of synthetic lipids and either synthetic or recom-
binant peptides (15). A synthetic lung surfactant formulation
was developed based upon a cationic and hydrophobic 21-
residue peptide (KL4) (KLLLLKLLLLKLLLLKLLLLK,
where ‘‘K’’ and ‘‘L’’ represent the amino acids lysine and
leucine, respectively). KL4 mimics the positive charge and
hydrophobic residue distribution of SP-B (16). This syn-
thetic surfactant is comprised of DPPC, POPG, PA, and KL4
at weight ratios of 28:9.3:5.0:1.0, respectively. The KL4
peptide concentration corresponds to 0.57 mol % and 2.3 wt
%. At this concentration, KL4 adopted a predominantly
a-helical secondary structure in these membranes, indepen-
dent of the presence of calcium (17), and is likely oriented
with its backbone parallel to the interface. The surface ac-
tivity of KL4 peptide incorporated in surfactant-like bilayers
and monolayers is well recognized (16–19). KL4-surfactant
(Surfaxin) has been found to be very effective in clinical
trials of human RDS (20,21), in experimental and clinical
meconium aspiration syndrome (22,23), and in patients with
ARDS (24).
The effect of enrichment of KL4-surfactant with SP-A on
its biophysical activity is unknown. SP-A might interact with
the cationic and hydrophobic peptide KL4 inserted in the
membrane surface given the negative charge in the SP-A
surface (25) with pI varying between pH 4.5 and 5.2. The
aims of this study were to determine SP-A effects on
physical properties and lateral lipid organization of KL4-
containing surfactant-like membranes and to determine
whether supplementation of KL4-surfactant with SP-A re-
sults in improvement or impairment of its surface activity.
Parallel experiments were performed with a porcine LES as a
benchmark of natural surfactant. We found that SP-A had a
concentration-dependent effect on the surface activity of
KL4-DPPC/POPG/PA membranes but not on that of LES,
which contains all the lipid associated with surfactant plus
the hydrophobic surfactant proteins SP-B and SP-C. Our
results demonstrate that, at physiological concentrations,
SP-A improved the efﬁcacy of KL4-surfactant. However, at
SP-A supraphysiological concentrations, the surface activity
of this synthetic surfactant diminished as a consequence of
the ﬂuidizing effect of SP-A on surfactant-like membranes
with, but not without, KL4.
MATERIALS AND METHODS
Materials
Synthetic lipids DPPC, POPG, and PA were purchased from Avanti Polar
Lipids (Birmingham, AL). The organic solvents (methanol and chloroform)
used to dissolve lipids were HPLC-grade (Scharlau, Barcelona, Spain).
Bodipy-PC and DPH were purchased from Molecular Probes (Eugene, OR).
All other reagents were of analytical grade and obtained from Merck
(Darmstadt, Germany).
MLVs of DPPC/POPG/PA (28:9.4:5.1, w/w/w), containing different
amounts of KL4 peptide, were prepared as previously reported (17). The
sample solutions were prepared by mixed stock solution of the lipid and the
peptide, both prepared in chloroform/methanol, to achieve the desired lipid/
peptide ratio.
Isolation of SP-A
SP-A was isolated from bronchoalveolar lavage of patients with alveolar
proteinosis using a sequential butanol and octylglucoside extraction (8). The
purity of SP-A was checked by one-dimensional SDS-PAGE in 12%
acrylamide under reducing conditions and mass spectrometry. Quantiﬁca-
tion of SP-A was carried out by amino acid analysis in a Beckman System
6300 High Performance analyzer (Beckman Instruments, Palo Alto, CA).
The oligomerization state of SP-A was assessed by electrophoresis under
nondenaturing conditions and electron microscopy as reported elsewhere
(26,27). SP-A isolated from alveolar proteinosis patients consisted of
supratrimeric oligomers of at least 18 subunits. Each subunit had an apparent
molecular weight of 36,000.
Isolation and analysis of pulmonary surfactant
and LES
Pulmonary surfactant from porcine lungs was obtained as previously
described (28,29). Brieﬂy, cell-free bronchoalveolar lavage was centrifuged
at 100,0003 g for 2 h at 4C to obtain the large surfactant aggregates in the
resulting pellet. The separation of pulmonary surfactant from blood
components was performed by NaBr density-gradient centrifugation at
116,0003 g for 2 h at 4C. Surfactant has a density of;1.085 at 4C, which
is lower than that of most of the contaminating components of serum.
LES, which contains surfactant lipids, SP-B, and SP-C, was prepared by
chloroform/methanol extraction of isolated surfactant (28). The organic
solvent was then evaporated to dryness under a stream of nitrogen, and
traces of solvent were subsequently removed by evacuation under reduced
pressure overnight. MLVs of LES were prepared by hydrating the dry
proteolipid ﬁlm in buffer A containing 150 mM NaCl, 25 mM Hepes, pH
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7.0, and allowing them to swell for 1 h at 45C. After vortexing, the resulting
MLVs were used for different assays.
Total PL was determined from aliquots of both native surfactant and LES
by phosphorus analysis. PL classes were determined in the organic extract of
porcine surfactant by TLC as in Casals et al. (28,29). Total surfactant Ch was
determined enzymatically using the Sigma Diagnostic Cholesterol Kit. SP-B
and SP-C content was determined in organic extracts of porcine surfactant
using ELISA procedures described previously (30,31). For SP-B measure-
ment, an anti-porcine SP-B antiserum was used. For SP-C measurement, an
anti-recombinant human SP-C antiserum (generously donated by Altana
Pharma, Konstanz, Germany) was used. There was cross-reactivity of this
antiserum with porcine SP-C. The detection limit for porcine SP-C was 180
6 2.5 ng/ml.
Adsorption assays
The ability of LES and DPPC/POPG/PA vesicles, with or without 0.57 mol
% KL4, to absorb onto and spread at the air-water interface was tested in the
absence and presence of different amounts of SP-A in a Wilhelmy-like
highly sensitive surface microbalance (17,26,27,29). The lipid mixtures
were injected into the hypophase chamber of the Teﬂon dish, which
contained 6 ml of buffer A either with or without 5 mM CaCl2 in the
presence and absence of SP-A. Interfacial adsorption was measured after
the change in surface tension as a function of time. For each preparation, the
analysis was repeated at least three times.
Emission anisotropy measurements
The required amounts of the stock solutions of DPPC/POPG/PA and KL4
were mixed with DPH at a probe/PL molar ratio of 1:200 (ﬁnal PL
concentration of 1 mg/ml) as previously described (17,32). In cases where
DPH was incorporated into LES, the probe dissolved in methanol was added
to organic extracts of native surfactant at a DPH/PL molar ratio of 1:200
before solvent removal. DPH concentration was determined spectrophoto-
metrically by absorbance at a wavelength of 350 nm, using a molar
extinction coefﬁcient in methanol of 88,000 M1 cm1. LES and DPPC/
POPG/PA vesicles, with or without KL4, were prepared in buffer B (20 mM
Tris-HCl, 130 mM NaCl, pH 7.6). Exposure to light was minimized
throughout the vesicle preparation process. An appropriate amount of SP-A
in buffer B was added to each aliquot of either LES, KL4-DPPC/POPG/PA
vesicles, or vesicles without KL4 to give the desired ﬁnal concentration of
protein, with a ,5% increase in volume for each aliquot.
Steady-state ﬂuorescence emission anisotropy measurements were
carried out using an SLM-Aminco AB-2 spectroﬂuorimeter equipped with
Glam prism polarizers and a thermostated cuvette holder (60.1C) (Thermo
Spectronic, Waltham, MA), using 53 5 mm path-length quartz cuvettes, as
previously described (17,26,32). For each sample, ﬂuorescence emission
intensity data in parallel and perpendicular orientations with respect to the
exciting beam were collected 10 times each and then averaged. Background
intensities in DPH-free samples due to the vesicles and SP-A were sub-
tracted from each recording of ﬂuorescence intensity. lm and lx were set at
360 and 430 nm, respectively. Anisotropy, r, was calculated as
r ¼ Ill  G  I?
Ill1 2G  I?;
where Ill and I? are the parallel and perpendicular polarized intensities
measured with the vertically polarized excitation light and G is the mono-
chromator grating correction factor.
Differential scanning calorimetry
Calorimetric measurements were performed as previously reported (17,32)
in a Microcal VP differential scanning calorimeter (Microcal, Northampton,
MA) at a heating rate of 0.5C/min. DPPC/POPG/PAMLVs (1 mM) with or
without 0.57 mol % KL4 and in the presence of different amounts of SP-A
were loaded in the sample cell of the microcalorimeter with 0.6 ml of buffer
A in the reference cell. Experiments were also performed using native
surfactant (1 mg/ml, total PL concentration) and LES (1 mg PL/ml) with or
without different amounts of SP-A. Three calorimetric scans were collected
from each sample between 15C and 70C. The standard Microcal Origin
software was used for data acquisition and analysis. The excess heat capacity
functions were obtained after subtraction of the buffer-buffer baseline.
Giant vesicle preparation
GUVs composed of 1), native surfactant, 2), LES, 3), KL4-DPPC/POPG/
PA, and 4), DPPC/POPC/PA were prepared from lipid samples suspended in
buffer B (no organic solvents) as described previously (17,33) by using the
electroformation method originally developed by Angelova and Dimitrov
(34). GUVs composed of LES, KL4-DPPC/POPG/PA, and DPPC/POPG/
PA were prepared in the absence and presence of different amounts of SP-A.
A special temperature-controlled chamber was used for this purpose (35).
Brieﬂy;3 ml of the stock suspension in buffer B in the presence or absence
of SP-A were spread in small drops on the surface of each platinum wire.
The sample was labeled with Bodipy-PC, the percentage of ﬂuorescent
probe in the sample being ,0.1 mol % (17). The chamber was then placed
under a stream of N2 and subsequently under low vacuum for 30 min to
allow the native material to adsorb onto the platinum wire. An important
point in this step is to avoid dehydration of the sample to maintain the
integrity of the membranes. Once the material was adsorbed to the platinum
wire, aqueous solution was added to the chamber (200 mosM sucrose
solution prepared with Millipore-ﬁltered water, 17.5 megohms/cm). The
sucrose solution was previously heated to the desired temperature (above the
lipid mixture phase transition), and then sufﬁcient volume was added to
cover the platinum wires (;300 ml). The platinum wires were connected
immediately to a function generator (Digimess FG 100) (Vann Draper
Electronics, Derby, UK), and a low frequency alternating current ﬁeld
(sinusoidal wave function with a frequency of 10 Hz and amplitude of 3 V)
was applied for 60 min. After vesicle formation, the alternating current ﬁeld
was turned off, and the vesicles were collected with a pipette and transferred
into a plastic tube.
Observation of giant vesicles
Aliquots of giant vesicles suspended in sucrose were added to an isoosmolar
concentration of glucose solution. The density difference between the
interior and exterior of the GUVs induces the vesicles to sink to the bottom
of the chamber, and within a few minutes the vesicles are ready to be
observed using an inverted microscope. GUV preparations were observed in
12-well plastic chambers (Lab-Tek Brand Products, Naperville, IL). The
chamber was located in an inverted confocal microscope (Zeiss LSM 510
META, Zeiss, Jena, Germany) for observation. The excitation wavelength
was 488 nm. The temperature was controlled from a water bath connected to
a homemade device into which the 12-well plastic chamber was inserted.
The temperature was measured inside the sample chamber using a digital
thermocouple (model 400B, Omega, Stamford, CT) with a precision of
0.1C. Unilamellarity was assured by measuring the ﬂuorescence intensity
of the equator region as described previously (36).
RESULTS
SP-A concentration-dependent effect on the
surface activity of KL4-surfactant
Fig. 1 shows SP-A effects on the surface activity of DPPC/
POPG/PA vesicles with (right panel) and without (left panel)
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0.57 mol % KL4 in the presence of calcium. The ﬁnal PL
concentration was 70 mg/ml. Addition of different SP-A
concentrations to KL4-containing DPPC/POPG/PA vesicles
led to SP-A concentration-dependent changes in the surface
properties of these vesicles. Thus at protein/PL weight ratios
of 2.5% and 5%, the adsorption rate of these vesicles
signiﬁcantly increased. At SP-A concentrations $10 wt %,
the surface activity of KL4-surfactant decreased (Fig. 1, right
panel). On the contrary, addition of different SP-A concen-
trations (2.5–20 wt %) to DPPC/POPG/PA membranes
without KL4 signiﬁcantly enhanced the surface adsorption
rate of these vesicles, although the equilibrium pressure was
not attained in the absence of KL4 (Fig. 1, left panel).
To ﬁnd out whether the effects of SP-A on the surface
activity of KL4-surfactant were inﬂuenced by the presence of
Ca21, we performed these experiments in the absence of this
cation (Fig. 2). We found that the SP-A concentration-
dependent effects on the adsorption rate of these vesicles
were similar in the absence and presence of calcium.
However, in the absence of calcium, it was necessary to
increase the amount of surfactant PLs to attain the equilib-
rium pressure (from 70 mg/ml with Ca21 to 100 mg/ml
without Ca21). Collectively, these data revealed that the
SP-A concentration-dependent behavior on the surface ac-
tivity of KL4-DPPC/POPG/PA membranes was independent
of calcium.
SP-A decreases the ordering effect of KL4 on
surfactant-like membranes
We previously showed that KL4 has an ordering effect on
DPPC/POPG/PA membranes which is dependent on KL4
concentration (17). Given that the binding of 10 wt % SP-A
to KL4-DPPC/POPG/PA membranes decreased its surface
activity, we investigated whether addition of 10 wt % SP-A
interfered with the KL4 ordering effect. Fig. 3 shows that
increasing the KL4 concentration in DPPC/POPG/PA ves-
icles resulted in signiﬁcant increase in the steady-state
emission anisotropy of DPH incorporated in those vesicles.
However, in the presence of 10 wt % SP-A, the KL4 effect on
DPH anisotropy was partially inhibited. Because an increase
in the steady-state anisotropy of DPH embedded in vesicles
containing KL4 might be due to greater molecular order of
the lipids surrounding DPH and a consequent slowing in
DPH rotational diffusion, or to changes in DPH ﬂuorescence
lifetime and hence changes in DPH steady-state ﬂuorescence
intensity (37), we also measured the ﬂuorescence emission
spectra of DPH embedded in KL4-containing vesicles in the
absence and presence of SP-A upon excitation at 360 nm as
reported elsewhere (17,32). Within experimental error, no
changes were observed in the ﬂuorescence emission of DPH
with increasing amounts of peptide, both in the absence and
presence of SP-A (data not shown). This allows us to infer
FIGURE 1 Effect of SP-A on the adsorption kinetics of
DPPC/POPG/PA membranes with or without 0.57 mol %
KL4 in the presence of 5 mM calcium. PL interfacial
adsorption was measured at 25C after the change in
surface pressure as a function of time for samples
containing 70 mg PL/ml in the absence (solid black circle)
and presence of increasing amounts of SP-A: (s) 2.5%,
(4) 5.0%, (light shaded circle) 10%, and (dark shaded
circle) 20% protein/lipid weight ratio (which correspond to
1.75, 3.5, 7, and 14 mg/ml SP-A, respectively). Values are
the mean 6 SD of three experiments. Similar results were
obtained at 37C.
FIGURE 2 Calcium-independent effect of SP-A on the
adsorption kinetics of DPPC/POPG/PA membranes with
or without 0.57 mol % KL4. PL interfacial adsorption was
measured at 25C after the change in surface pressure as a
function of time for samples containing 100 mg PL/ml in
the absence (solid black circle) and presence of increasing
amounts of SP-A: (s) 2.5%, (light shaded circle) 10%,
and (dark shaded circle) 20% protein/lipid weight ratio
(which correspond to 2.5, 5, 10, and 20 mg/ml SP-A,
respectively). Values are the mean 6 SD of three
experiments. Similar results were obtained at 37C.
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that the observed increase in DPH anisotropy was due to
greater lipid order. Thus results indicate that KL4 enhanced
the lipid order of DPPC/POPG/PA membranes as described
previously (17) and SP-A partially inhibited the KL4-
dependent ordering effect.
Next we examined the emission anisotropy of DPH
embedded in DPPC/POPG/PA membranes with and without
0.57 mol % KL4 as a function of SP-A concentration at 37C.
Fig. 4 shows that, in the absence of SP-A, the anisotropy
values of DPH were higher in samples containing 0.57 mol
% KL4, which indicates a peptide-promoted increased lipid
order (17). Addition of different amounts of SP-A to KL4-
containing DPPC/POPG/PA membranes caused a protein
concentration-dependent decrease of the anisotropy values
of DPH. At 10 wt % SP-A, the anisotropy values of these
membranes with or without KL4 were similar. The lack of
changes in the ﬂuorescence of the probe upon addition of
SP-A (data not shown) allows us to infer that SP-A decreases
the lipid order of KL4-surfactant membranes. These results
clearly indicate that SP-A interacts with KL4 incorporated
in surfactant-like membranes and that SP-A, at a protein/
lipid weight ratio of 10%, abrogates the ordering effect of
0.57 mol % KL4 on these membranes.
SP-A effects on the thermotropic properties
of KL4-surfactant
We used steady-state DPH anisotropy to measure the effect
of 10 wt % SP-A on the thermotropic behavior of KL4-
containing membranes (Fig. 5). The ﬂuorescence anisotropy
of DPH decreases at temperatures higher than the Tm because
the rotational freedom of the probe increases upon PL acyl
chain melting (37). The phase transition temperature results
from a condition of disorder due to the trans-gauche-
isomerization of PL acyl chains. In the presence of 10 wt %
SP-A, the ﬂuorescence anisotropy of DPH signiﬁcantly
decreased in the solid/ﬂuid transition region of KL4-DPPC/
POPG/PA vesicles, but it slightly increased in the liquid-
crystalline phase. This indicates that supraphysiological
concentrations of SP-A had a ﬂuidizing effect on KL4-
surfactant at temperatures where the solid/ﬂuid transition
occurred. In addition, Fig. 5 shows that SP-A shifted the
main transition temperature (Tm) of these vesicles somewhat
downward. In the presence of SP-A, the temperature-
dependent ﬂuorescence anisotropy change of DPH incorpo-
rated into KL4-DPPC/POPG/PA vesicles resembled that
obtained for DPPC/POPG/PA vesicles without KL4 (data not
shown), indicating that SP-A revoked KL4 effects on DPPC/
POPG/PA membranes.
We also used the nonperturbing technique of DSC to
probe the effect of SP-A on the thermotropic properties of
DPPC/POPG/PA vesicles with and without 0.57 mol % KL4
(Fig. 6). The thermal transition of KL4-containing DPPC/
POPG/PA membranes was characterized by a complex
FIGURE 3 Steady-state emission anisotropy of DPH incorporated in
DPPC/POPG/PA vesicles (1 mM) containing different concentrations of
KL4 in the absence (d) and presence (s) of SP-A at a protein/lipid weight
ratio of 10%. Experiments were performed at 37C. (lx¼ 360 nm, lm¼ 430
nm). Values are the mean 6 SD of three experiments.
FIGURE 4 Effect of increasing SP-A concentrations on the steady-state
emission anisotropy of DPH incorporated in DPPC/POPG/PA membranes
(1 mM) in the absence (h) and presence (n) of 0.57 mol % KL4.
Experiments were performed at 37C (lx ¼ 360 nm, lm ¼ 430 nm). Values
are the mean 6 SD of three experiments.
FIGURE 5 Temperature-dependent ﬂuorescence anisotropy of DPH
incorporated into KL4-DPPC/POPG/PA vesicles in the absence (s) and
presence (w) of 10 wt % SP-A. The ﬁnal concentrations of PLs and SP-A
were 1 mg/ml and 100 mg/ml, respectively. Values are the mean 6 SD of
three experiments. The standard deviation for each temperature was too
small to be displayed by error bars. (lx ¼ 359 nm, lm ¼ 427 nm).
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double peak with one relatively sharp peak and a small peak
on the low temperature side of the main transition, as
described in Saenz et al. (17) (Fig. 6, right panel). This
double peak is only observed in POPG-containing vesicles
(17), indicating that it must be generated by electrostatic
interactions between the positively charged lysine residues
of KL4 and the anionic headgroup of POPG (17). Addition of
increasing amounts of SP-A perturbed the thermal transition
of these KL4-containing membranes. Thus, whereas the
sharp peak shifted slightly to lower temperatures, the height
of the small and broad peak increased and shifted to higher
temperatures. In the presence of 20 wt % SP-A, the mem-
branes showed an endotherm with a main transition to the
liquid-crystalline phase at 49.1 6 0.1C. Importantly,
whereas KL4 shifted the main transition temperature (Tm)
of surfactant-like vesicles somewhat upward (from 48.5 to
50.0C for DPPC/POPG/PA) (17), the presence of 10–20 wt
% SP-A produced the opposite effect. That is, high
concentrations of SP-A shifted the Tm somewhat downward,
which is consistent with DPH anisotropy experiments shown
in Fig. 5.
Fig. 6 (left panel) shows endotherms of DPPC/POPG/PA
membranes without KL4 in the absence and presence of
SP-A. In contrast to KL4-DPPC/POPG/PA vesicles, addition
of increasing amounts of SP-A to DPPC/POPG/PA vesicles
led to a protein-concentration-dependent increase in the Tm.
Moreover, the interaction of SP-A with these vesicles
induced some perturbation of the lipid molecular packing
so that a narrowing of the phase transition was observed.
This could indicate SP-A-mediated stabilization of DPPC-
rich assemblies. It is important to note that the thermograms
of KL4-DPPC/POPG/PA vesicles containing SP-A (Fig. 6,
right panel) were not similar to those of the lipids without
KL4 containing SP-A (Fig. 6, left panel). Therefore, it could
be inferred that KL4 is not withdrawn from the membrane by
high concentrations of SP-A. Visualization of the effects of
SP-A on these vesicles with and without KL4 (Figs. 7 and 8)
conﬁrms this hypothesis.
SP-A effects on the lipid lateral organization of
KL4-containing surfactant-like membranes
Confocal ﬂuorescence microscopy was employed to visual-
ize SP-A effects on the lipid lateral organization of GUVs
prepared from DPPC/POPG/PA vesicles with and without
0.57 mol % KL4. The membranes were doped with the
ﬂuorescent probe Bodipy-PC. As described previously (17),
DPPC/POPG/PA vesicles, with or without KL4, showed
coexisting bright and dark domains at room temperature,
well below their Tm (Figs. 7 and 8). Since Bodipy-PC
partitions in the ﬂuid phase (38), dark regions can be as-
cribed to DPPC-rich solid domains.
Electrostatic repulsions favor the formation of GUVs (39).
Given that KL4 electrostatically interacts with POPG and PA
(17,18), decreasing the net negative charge of DPPC/POPG/
PA vesicles, the formation of GUVs was reduced in the
FIGURE 6 Effect of SP-A on DSC heating scans of DPPC/POPG/PA
vesicles (1 mM) with or without 0.57 mol % KL4. The % SP-A/lipid weight
ratio is indicated on each thermogram. Calorimetric scans were performed at
a rate of 0.5C/min. For clarity of presentation the tick labels of heat capacity
(Cp) are not shown. For each thermogram, the scale of Cp was from 0 to 1.4.
One representative experiment of three experiments is shown.
FIGURE 7 SP-A effects on the lipid lateral organization
of GUVs prepared from KL4-DPPC/POPG/PA MLVs
doped with the ﬂuorescent probe Bodipy-PC. Images were
taken at 25C. The lipid concentration used was 0.2 mg/ml.
SP-A concentrations were 5, 20, and 40 mg/ml. The scale
bars correspond to 5 mm.
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presence of KL4, which also induced vesicle aggregation as
shown in (17). Therefore, the yield of individual GUVs was
very low in the presence of KL4 (17). Interestingly, the
binding of SP-A to KL4-DPPC/POPG/PA vesicles favored
the formation of GUVs. We found that addition of SP-A at
concentrations$2.5 wt % dramatically increased the yield of
GUVs and no aggregates were observed. This could be
explained by the fact that the binding of SP-A to KL4-DPPC/
POPG/PA vesicles would contribute negative charge to these
vesicles. Fig. 7 shows that the shape, size, and number of
DPPC-rich solid domains were similar in the absence and
presence of 2.5 wt % SP-A. However, increasing the SP-A
concentration up to 10 wt % resulted in changes in the shape
and size of DPPC-rich solid domains. Solid domains were
less apparent and formed narrow stripes as shown in Fig. 7.
At a protein/lipid weight ratio of 20 wt %, the ﬂuorescence of
the dye was uniform over the GUV surface, indicating either
that there is a single phase or that solid domains have much
smaller dimensions than the optical resolution (Fig. 7).
Collectively, these results indicated that supraphysiological
concentrations of SP-A increased the ratio of ﬂuid/solid
domains of KL4-DPPC/POPG/PA membranes, resulting in
disappearance of the solid/ﬂuid phase coexistence distinctive
of these vesicles.
On the other hand, we did not ﬁnd this SP-A ﬂuidizing
effect on GUVs prepared from DPPC/POPG/PA in the
absence of KL4 (Fig. 8). We previously reported that SP-A
recognizes the lipid in the gel phase (40) but can only
penetrate into the membrane interface in lipid-packing
defects at solid/ﬂuid boundaries (41–43). Here we found
that addition of 2.5 wt % SP-A to DPPC/POPG/PA vesicles
increased the number of solid domains and decreased their
size (Fig. 8). These results are consistent with our previous
ﬁndings on SP-A’s ability to reduce the size and increase the
number of condensed domains of DPPC monolayers (41).
Increasing the SP-A concentration up to 10 wt % led to
changes in the shape of the solid domains, which became
elongated as connected bands on the surface of these ves-
icles. The change in the size and shape of the DPPC-rich
solid domain of DPPC/POPG/PA vesicles induced by 2.5–
10 wt % SP-A can be explained by electrostatic repulsion
between SP-A and both POPG and PA, which would favor
strip-like structures. This hypothesis was conﬁrmed by
envisioning the effect of 10 wt % SP-A on DPPC/POPC/PA
vesicles or DPPC/POPG/PA vesicles in the presence of
calcium (data not shown). In both cases, the sizes of the
DPPC-rich domains were not reduced and the shapes were
circular. Separation of the solid phase into more numerous
domains in vesicles containing anionic PLs increases the
distance between their dipole moments, resulting in lower
electrostatic repulsion (44,45). Interestingly, further increas-
ing the SP-A concentration up to 20 wt % resulted in the
formation of larger DPPC-rich solid domains (Fig. 8). The
formation of such large circular solid domains at high SP-A
concentrations (20% by weight) is intriguing. It is possible
that, at 20 wt % SP-A, the electrostatic repulsions between
the protein and negatively charged lipids (POPG and PA)
partially prevent the interaction of the protein with the
membrane. On the contrary, in KL4-DPPC/POPG/PA ves-
icles, the charge neutralization of the membrane induced by
KL4 would favor the interaction of SP-A with the vesicles,
leading to membrane perturbation and disappearance of the
solid/ﬂuid phase coexistence.
SP-A effects on the surface activity and physical
properties of porcine lipid extract surfactant
We also studied the effect of SP-A on the surface activity
and physical properties of a LES obtained from porcine
bronchoalveolar ﬂuid to compare SP-A effects on KL4-
surfactant with those on natural surfactant. Porcine LES
consisted of PL vesicles that contain ;10–15 mol % Ch and
the hydrophobic surfactant proteins SP-B and SP-C as the
only protein constituents. The PL composition of these
vesicles was PC (79%), phosphatidylinositol (8%), PG (4%),
phosphatidylserine (2%), phosphatidylethanolamine (3%),
sphingomyelin (2.5%), and lysophosphatidylcholine (1.5%)
as previously reported (46). The content of hydrophobic
proteins in porcine LES, detected by ELISA, was 1.7 nmol
SP-B/mmol PL and 3.5 nmol SP-C/mmol PL. We did not
measure the content of DPPC, the molecular species of PC
distinctive of lung surfactant, but it is reported that DPPC
constitutes 60 mol % of the total lung surfactant PC from
adult pigs (47).
Fig. 9 A shows surface adsorption kinetics of porcine LES
with and without SP-A at a concentration of surfactant PL of
50 mg/ml. This low concentration of surfactant material was
deliberately chosen to obtain a measurable effect of SP-A on
FIGURE 8 SP-A effects on the lipid lateral organization
of GUVs prepared from DPPC/POPG/PA MLVs doped
with the ﬂuorescent probe Bodipy-PC. Images were taken
at 25C. Lipid and SP-A concentrations were as in Fig. 7.
The scale bars correspond to 5 mm.
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the rate of change of surface pressure. Fig. 9 A shows that
SP-A concentrations as low as 1.5 wt % greatly enhanced the
surface adsorption rate, reaching the equilibrium surface
pressure (40–45 mN/m) at 8 min. Greater SP-A concentra-
tions (2.5, 10, or 20 wt %) had no further effect on surface
adsorption. In contrast to the results found with KL4-
surfactant, supraphysiological concentrations of SP-A ($10
wt %) had no inhibitory effect on the surface adsorption rate
of LES. These results are consistent with previous data that
demonstrated an SP-A-promoted increase of the surface
activity of lipid extracts from animal-derived surfactants
(9,26,27,48). This effect seemed to be independent of the
amount of SP-A added.
Fig. 9 B shows a representative DSC experiment obtained
from porcine lung surfactant, LES, and LES plus different
SP-A concentrations (2.5–20 wt %). The thermograms were
almost similar. They were characterized by a broad melting
event with low melting enthalpy likely due to the lipid
composition of lung surfactant membranes, which contained
Ch. Results in Fig. 9 B indicate that neither the absence of
SP-A in LES nor the addition of 10 or 20 wt % SP-A to LES
inﬂuenced the thermotropic behavior of these membranes.
Similar results were found using steady-state DPH anisot-
ropy to measure the effect of 10 or 20 wt % SP-A on the
thermotropic behavior of LES (Fig. 9 C).
Fig. 9 D shows images of single GUVs composed of
porcine lung surfactant, porcine LES, and LES plus 10 wt %
SP-A doped with the ﬂuorescent probe Bodipy-PC. GUVs
from lung surfactant and LES exhibited the typical liquid
ordered/liquid disordered-like phase coexistence previously
reported (33), which is characterized by the presence of
ﬂuorescent round domains over a dark background (33).
Alternatively, some images of surfactant and LES showed
dark solid domains over a ﬂuorescent background. Images
from surfactant and LES were very similar. This suggests
that the absence of the water-soluble fraction of surfactant in
LES (which included SP-A) had no effect on the lipid lateral
organization of these membranes, as reported previously (33).
Phase coexistence is a characteristic of such membranes and
occurs at room and physiological temperatures (33,49). In
contrast to the results found with KL4-surfactant, supraphys-
iological concentrations of SP-A did not increase the ratio
of ﬂuid/solid domains in LES and did not cause disappear-
ance of the solid/ﬂuid phase coexistence typical of these ves-
icles. Collectively, these results indicate that, in opposition to
the results found with KL4-surfactant, supraphysiological
FIGURE 9 Effect of SP-A on porcine LES, which contains the entire lipid associated with surfactant plus the hydrophobic surfactant proteins SP-B and SP-C.
(A) Adsorption kinetics of LES (50 mg/ml) in the absence and presence of 1.5, 2.5, 10, and 20 wt % SP-A; (B) DSC heating scans of porcine lung surfactant
(1 mg PL/ml) and porcine LES (1 mg PL/ml) in the absence and presence of 2.5, 10, and 20 wt % SP-A; (C) Effect of 10 wt % SP-A on the temperature-
dependent ﬂuorescence anisotropy of DPH incorporated into LES (1 mg/ml). Similar results were found with 20 wt % SP-A. In panels A–C one representative
experiment of two experiments is shown; (D) Representative confocal ﬂuorescence images of GUVs composed of porcine lung surfactant, LES, and LES plus
SP-A. The giant vesicles were labeled with the ﬂuorescent probe Bodipy-PC, which partitions in the ﬂuid phase. Images were taken at 25C. The lipid
concentration used was 0.2 mg/ml. The SP-A concentration was 20 mg/ml. The scale bar corresponds to 5 mm.
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concentrations of SP-A did not have a ﬂuidizing effect of
LES and improved the surface adsorption of these surfactant
membranes.
DISCUSSION
It is known that maintenance of a stable DPPC-rich surface
ﬁlm is essential for respiration and requires the surface ad-
sorption process. Surface adsorption involves rapid insertion
of PLs into the expanding ﬁlm, which requires conversion
from bilayer aggregates to interfacial ﬁlm (50,51). Both
SP-B and SP-C promote adsorption of PLs from vesicles in
the aqueous subphase into the air-liquid interface, but the
mechanism by which surfactant hydrophobic proteins pro-
motes bilayer-monolayer transitions is not understood (50,
51). On the other hand, studies with lipid extracts from lung
surfactant indicate that at low surfactant concentrations small
amounts of SP-A enhance the rate of surface adsorption (48).
Low or high (2–20 wt %) SP-A concentrations enhance
adsorption of lipids along the air-water interface in the pres-
ence of the hydrophobic surfactant protein SP-B (8,52,53).
In this study we have examined the effect of different
concentrations of SP-A on the surface adsorption of a syn-
thetic lung surfactant based upon the cationic and hydro-
phobic 21-residue peptide KL4 inserted in DPPC/POPG/PA
vesicles as well as on the physical properties and lateral lipid
organization of these membranes.
KL4 mimics the positive charge and hydrophobic residue
distribution of SP-B (16). KL4, as well as SP-B and SP-C,
promotes rapid adsorption of surfactant-like vesicles to an
air-water interface (16–19). This cationic peptide interacts
with anionic PLs (16–18) and has an ordering effect on
surfactant-like vesicles (17) comparable to that of SP-B
(54,55). KL4 causes immiscibility between DPPC and POPG
in bilayers (17) and monolayers (18), promoting lateral phase
separation, which could explain the better overall surface
adsorption of KL4-containing membranes. In this study we
found that concentrations of SP-A $10 wt % 1), decreased
the rate of surface adsorption of KL4-DPPC/POPG/PA mem-
branes; 2), abrogated KL4-induced ordering effect in these
membranes; and 3), increased miscibility between DPPC and
POPG, decreasing DPPC-rich solid domain fraction. This
caused disappearance of solid/ﬂuid phase coexistence of
KL4-DPPC/POPG/PA vesicles at high SP-A concentrations.
Our results suggest speciﬁc interactions between SP-A
and KL4 and also between SP-A and surfactant-like mem-
branes, which ﬁnally inﬂuence the surface behavior of the
whole system. Charge neutralization of the membrane in-
duced by KL4 would favor the interaction of negatively
charged SP-A with vesicles, leading to membrane perturba-
tion and disappearance of the solid/ﬂuid phase coexistence.
The strong effects of supraphysiological concentrations of
SP-A on the physical properties and lateral lipid organization
of KL4-DPPC/POPG/PA membranes might explain why
SP-A at high concentrations decreased the surface activity of
KL4-surfactant. We previously reported that the physical
state of the membrane plays a critical role in the surface
adsorption process mediated by low KL4 concentrations
(0.57 mol %) (17). Thus KL4-DPPC/POPG/PA and KL4-
DPPC/POPC/PA vesicles, which show well-deﬁned solid/
ﬂuid phase coexistence at temperatures below their Tm, ex-
hibit very rapid surface adsorption. In contrast, more ﬂuid
(DPPC/POPG) or excessively rigid (DPPC/PA)KL4-containing
membranes are unable to adsorb rapidly onto an air-water
interface (17). The fact that SP-A, at high concentrations,
led to a visible disappearance of the solid/ﬂuid phase coex-
istence distinctive of KL4-DPPC/POPG/PA vesicles and in-
hibited the surface activity of these vesicles argues that phase
coexistence has an important role in promoting surface
adsorption. This is consistent with the fact that phase
coexistence of liquid-ordered and liquid-disordered phases
exists in GUVs prepared from porcine lung surfactant or
LES as previously reported (33). In contrast to the results
found with KL4-surfactant, addition of high SP-A concen-
trations to LES did not affect the phase coexistence char-
acteristic of LES and signiﬁcantly enhanced the surface
adsorption rate of these membranes. Together, these results
suggest that phase coexistence in surfactant membranes is
important for the surface adsorption process. It is possible that
the presenceofﬂuidphases in the lateral organizationofDPPC-
rich surfactant bilayers facilitates fusion of vesicles to the air-
water interface, which implies bilayer disruption. Unsaturated
PLs, present in ﬂuid domains, might form transient, negatively
curved structures in the bilayer-monolayer transition as pro-
posed by Hall and co-workers (51,56,57) or rapidly ﬂip to the
air-water interface. This process could be mediated by
surfactant hydrophobic peptides (SP-B and/or SP-C) or KL4,
all of which are located in the ﬂuid phase (17,18,33).
On the other hand, physiological concentrations of SP-A
did not perturb phase coexistence of KL4-DPPC/POPG/PA
membranes and signiﬁcantly improved the rate of surface
adsorption of KL4-surfactant. Importantly, SP-A at either low
or high concentrations (2.5–20 wt %) enhanced the surface
activity of DPPC/POPG/PA membranes without KL4, al-
though the equilibrium pressure was not reached in the
absence of the peptide. Thus SP-A concentration-dependent
behavior on surface adsorption of KL4-surfactant seems to
depend on electrostatic interactions between SP-A and KL4,
which block KL4 effects on DPPC/POPG/PA membranes.
The mechanism by which SP-A at physiological concentra-
tions enhances the surface adsorption rate of KL4-DPPC/
POPG/PA membranes as well as of lipid extracts from
animal-derived surfactants (9,26,27,48) or lipid mixtures
containing SP-B or SP-B plus SP-C (8,52,53) is unknown, but
it must be related to the ability of SP-A to bind DPPC over
other lipids (40). SP-A could promote stabilization of DPPC-
rich assemblies. It is known that SP-A stimulates DPPC-
speciﬁc surface adsorption fromDPPC/POPG/POPCvesicles
containing SP-B (53). It is possible that the role of SP-A is just
to increase immiscibility betweenDPPC and POPG or POPC,
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whereas the role of SP-B or KL4, which speciﬁcally interact
with PG (16–18,54,58), is not only to cause immiscibility
between DPPC and POPG but also to promote the bilayer-
monolayer transition and hence overall spreadability of the
mixture.
In the future, synthetic surfactants containing recombinant
human SP-A might be routinely used in the treatment of lung
diseases, given that replacement surfactants containing 5 wt
% SP-A are superior to those surfactants lacking this
component (13,14) and that SP-A helps to prevent surfactant
inhibition by serum proteins (9). The ﬁnding that enrichment
of KL4-surfactant with SP-A at concentrations above a certain
limiting value may not improve but reduce the activity of this
synthetic surfactant is relevant to the preparation of SP-A-
enriched synthetic surfactants based upon KL4 or other
cationic and hydrophobic synthetic peptides that mimic
surface properties of SP-B.
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